← All trials
NCT05282459
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 12, 2022
- Primary completion
- Jan 31, 2024
- Completion date
- Jan 31, 2024
- First posted
- Mar 16, 2022
- Last posted
- May 19, 2022
- Enrollment
- 48
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Stanford UniversityLead sponsor
- CelgeneCollaborator
- Stanford UniversityOverall official - principal investigator
- Stanford UniversitySponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.